Comparison of ProSeal Laryngeal Mask Airway to Laryngeal Mask Airway Supreme

NCT ID: NCT00836095

Last Updated: 2016-04-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

52 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2013-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Laryngeal mask airway is a widely used device in routine anesthesia for airway management during surgery. It consists of a tube with an inflatable cuff that is inserted into the mouth after induction of general anesthesia. The Proseal Laryngeal mask airway and the Laryngeal mask airway Supreme are two variants of the Laryngeal mask airway. The laryngeal mask airway Supreme is a newer version of the laryngeal mask airway.

The research is being done to compare two variants of the laryngeal mask airway: the Proseal laryngeal mask airway and the Laryngeal mask airway Supreme. This study will determine if the newer model, the Laryngeal mask airway Supreme, is easier to insert and is better positioned than the older model, the Proseal laryngeal mask airway. Both models are approved for use by the FDA, and are routinely used to assure the airway during general anesthesia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adverse Effect of Unspecified General Anesthetics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Supreme LMA

Supreme Laryngeal mask airway is a new, single use laryngeal mask airway variant.

The choice of the airway device will be randomized by opening a sealed envelope immediately before induction. The airway device will be blindly inserted by an experienced attending anesthesiologist.

Group Type OTHER

Supreme Laryngeal mask airway

Intervention Type DEVICE

Supreme Laryngeal mask airway is a new, single use laryngeal mask airway variant

Proseal LMA

Proseal is a multiple use, variant of the laryngeal mask airway.

The choice of the airway device will be randomized by opening a sealed envelope immediately before induction. The airway device will be blindly inserted by an experienced attending anesthesiologist.

Group Type ACTIVE_COMPARATOR

Proseal laryngeal mask airway

Intervention Type DEVICE

Proseal is a multiple use, variant of the laryngeal mask airway

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Supreme Laryngeal mask airway

Supreme Laryngeal mask airway is a new, single use laryngeal mask airway variant

Intervention Type DEVICE

Proseal laryngeal mask airway

Proseal is a multiple use, variant of the laryngeal mask airway

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 - 75 years
* ASA I and II
* Mallampatti class: I and II
* Thyromental distance \> than 6.5 cm
* Interincisor distance \> than 3 cm
* BMI \< 35 Kg/m2
* Patients scheduled to undergo anesthesia with an LMA for minor extraperitoneal surgical procedures in supine position

Exclusion Criteria

* Weight \< 50 kg
* BMI \> 35 Kg/m2
* Pregnant patients
* Known or expected difficult airway
* Patients with active, untreated and unresolved gastroesophageal reflux
* Esophageal pathology, pulmonary pathology
* Laparoscopic procedures
* ENT procedures, gastrointestinal procedures, intraperitoneal surgical procedure
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Milton S. Hershey Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sonia Vaida

M.D, Vice Chair for Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sonia J Vaida, MD

Role: PRINCIPAL_INVESTIGATOR

Penn State

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

PennState Hershey Milton S. Hershey Medical Center

Hershey, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB 29920

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.